Wednesday, October 4, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from AstraZeneca
Steering Committee Member Chair
Breast Unit
Champalimaud Clinical Centre
Lisbon, Portugal
University of Milano
European Institute of Oncology
Milan,
Italy
Breast Cancer Division, Dana Farber Cancer Institute, Boston, MA
Vall d'Hebron University Hospital, Barcelona, Spain
Samsung Medical Center
South Korea
University of Milan, Italy
Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen, Astellas/Medivation, AstraZeneca, Celgene, Daiichi-Sankyo. Eisai, GE Oncology, Genentech, GlaxoSmithKline, Macrogenics, Medscape, Merck-Sharp, Merus BV, Mylan, Mundipharma, Novartis, Pfizer, Pierre-Fabre, prIME Oncology, Roche, Samsung Bioepis, Sanofi, Seattle Genetics, Teva
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; BMS; Daichii Sankyo; Lilly; Merck; Novartis; Pfizer; Roche; Veracyte
Served as a speaker or a member of a speakers bureau for: Roche; Veracyte
Received grants for clinical research from: Merck
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Celltrion; Daiichi Sankyo; Genentech/Roche; Macrogenics
Received grants for clinical research from: Genentech/Roche; Pfizer
Other: Merck (DSMB member); Novartis (DSMB Member)
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbvie; AstraZeneca; Bayer; Blue Print Medicines; Boehringer-Ingelheim; Bristol-Myers Squibb; Eli Lilly; GSK; Guarant Health; Janssen; Merck; MSD; Novartis; Pfizer; Roche; Takeda
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eli Lilly; Medscape; MSD; Novartis; Pfizere; Prime Oncology; Roche; Takeda; TopChem
Received grants for clinical research from: Merck; Oncology Innovation (GOI) Fundacion; Salud
Other: Independent Member of the Board Grifols
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Mirati; Oncologie; Seattle Genetics
Received grants for clinical research from: AstraZeneca; Merck; MSD
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Bayer; Daichii Sankyo; Dako-Agilent; Eli-Lilly; Menarini; MSD Oncology; Novartis; Roche/Genentech
Served as a speaker or a member of a speakers bureau for: Bayer; Roche/Genentech
Received grants for clinical research from: Cepheid; Dako-Agilent; Ventana
